Pages that link to "Q50801058"
Jump to navigation
Jump to search
The following pages link to Ovarian cancer screening with annual transvaginal sonography: findings of 25,000 women screened (Q50801058):
Displaying 50 items.
- Hypodontia and ovarian cancer: A systematic review (Q26749467) (← links)
- In 2014, can we do better than CA125 in the early detection of ovarian cancer? (Q26825152) (← links)
- Ovarian cancer screening--current status, future directions (Q27004471) (← links)
- Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model (Q30417587) (← links)
- Integration of cell phone imaging with microchip ELISA to detect ovarian cancer HE4 biomarker in urine at the point-of-care (Q30449569) (← links)
- Quantitative multiparametric MRI of ovarian cancer (Q30612682) (← links)
- Cancer screening: a mathematical model relating secreted blood biomarker levels to tumor sizes (Q33361745) (← links)
- The preclinical natural history of serous ovarian cancer: defining the target for early detection (Q33487678) (← links)
- Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial (Q33761938) (← links)
- A Resident's Perspective of Ovarian Cancer (Q33850471) (← links)
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass (Q33862961) (← links)
- Early detection of ovarian cancer (Q34094731) (← links)
- Ovarian cancer biomarkers for molecular biosensors and translational medicine (Q34150097) (← links)
- Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis (Q34173704) (← links)
- Analysis of serial ovarian volume measurements and incidence of ovarian cancer: implications for pathogenesis (Q34209092) (← links)
- The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review (Q34363510) (← links)
- Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. (Q34579547) (← links)
- SGO White Paper on ovarian cancer: etiology, screening and surveillance (Q34622294) (← links)
- ACR Appropriateness Criteria© Ovarian Cancer Screening (Q34625217) (← links)
- Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. (Q34911466) (← links)
- Potential markers for detection and monitoring of ovarian cancer. (Q34960174) (← links)
- Ovarian volume throughout life: a validated normative model (Q34982658) (← links)
- Diagnostic potential of multimodal imaging of ovarian tissue using optical coherence tomography and second-harmonic generation microscopy (Q35194782) (← links)
- Screening tests: a review with examples (Q35317799) (← links)
- Evaluation of ovarian cancer biomarkers HE4 and CA-125 in women presenting with a suspicious cystic ovarian mass (Q35663640) (← links)
- Early detection of breast, cervical, ovarian and endometrial cancers in low resource countries: an integrated approach (Q35737322) (← links)
- Design of optimal light delivery system for co-registered transvaginal ultrasound and photoacoustic imaging of ovarian tissue (Q35861928) (← links)
- Modeling the Dynamics of High-Grade Serous Ovarian Cancer Progression for Transvaginal Ultrasound-Based Screening and Early Detection (Q36039369) (← links)
- Analysis of second-harmonic-generation microscopy in a mouse model of ovarian carcinoma (Q36075663) (← links)
- Quality assurance and its impact on ovarian visualization rates in the multicenter United Kingdom Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) (Q36584440) (← links)
- Potential tumor biomarkers identified in ovarian cyst fluid by quantitative proteomic analysis, iTRAQ. (Q36797835) (← links)
- Management of the asymptomatic BRCA mutation carrier (Q36925172) (← links)
- GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012. (Q36962482) (← links)
- Clinical Efficacy of Ovarian Cancer Screening. (Q37068015) (← links)
- Early detection of ovarian and fallopian tube cancer by examination of cytological samples from the endometrial cavity. (Q37081960) (← links)
- Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing (Q37185670) (← links)
- An outlook on ovarian cancer and borderline ovarian tumors: focus on genomic and proteomic findings (Q37260040) (← links)
- Ovarian cancer pathogenesis: a model in evolution (Q37335660) (← links)
- Ovarian cancer screening and early detection (Q37622987) (← links)
- Subtypes of Ovarian Cancer and Ovarian Cancer Screening (Q37729974) (← links)
- Is there a link between ovarian cancer and tooth agenesis? (Q37732372) (← links)
- Peri- and post-menopausal incidental adnexal masses and the risk of sporadic ovarian malignancy: new insights and clinical management. (Q37760524) (← links)
- Ultrasound and Ovarian Cancer Screening: Is There a Future? (Q37825100) (← links)
- Management of the Adnexal Mass (Q37878822) (← links)
- Ultrasound for evaluation of adnexal malignancy: from 2D to 3D ultrasound (Q37932056) (← links)
- Modern trends into the epidemiology and screening of ovarian cancer. Genetic substrate of the sporadic form. (Q37967486) (← links)
- Nonvisualization of the ovaries on pelvic ultrasound: does MRI add anything? (Q38165743) (← links)
- Sonographers' self-reported visualization of normal postmenopausal ovaries on transvaginal ultrasound is not reliable: results of expert review of archived images from UKCTOCS. (Q38372424) (← links)
- The role of biomarkers in the management of epithelial ovarian cancer (Q39281140) (← links)
- Screening for ovarian cancer: imaging challenges and opportunities for improvement. (Q43557526) (← links)